International Journal of
Advanced Multidisciplinary Application

Volume 3, Issue 4

• Author(s)François Beaumont, Katarzyna Wiśniewska, Dimitris Papadopoulos, Lars Eriksson
• AffiliationDepartment of Cardiology and Preventive Medicine, Université Paris Cité, Paris, France
• Page No.21-26
• Volume, Issue & YearVolume 3, Issue 4, April 2026
• Published On2026/04/02
• JournalInternational Journal of Advanced Multidisciplinary Application (IJAMA)
• ISSN No.3048-9350
• DOIhttps://doi.org/10.5281/zenodo.19438342

Article Indexing

Abstract

Hypertension remains the single most prevalent modifiable risk factor for cardiovascular disease globally, contributing to an estimated 10.4 million deaths annually and accounting for a disproportionate share of the cardiovascular disease burden across European populations. Despite substantial advances in antihypertensive pharmacotherapy, rates of blood pressure control remain suboptimal in most European countries, with surveys indicating that fewer than 40 percent of hypertensive individuals achieve the European Society of Cardiology recommended target of below 130/80 mmHg. This prospective multi-centre cohort study enrolled 6,248 hypertensive adults aged 40–80 years across twelve cardiology clinics in France, Poland, Greece, and Sweden, following participants for five years to characterise major adverse cardiac event (MACE) outcomes, blood pressure trajectory, and modifiable risk factor burden.
A structured cardiovascular risk reduction intervention combining intensified antihypertensive pharmacotherapy, lifestyle modification counselling, and telemedicine-supported home blood pressure monitoring was tested against standard care in a randomised sub-cohort (n=6,248; 3,124 per arm). The intervention arm achieved a mean systolic blood pressure reduction of 34.0 mmHg from baseline (158.4 to 124.4 mmHg) compared to 6.0 mmHg in the control arm. Five-year MACE-free survival was significantly higher in the intervention arm (83.9% vs. 72.6%; HR=0.68, 95% CI 0.58–0.79, p<0.001). Multivariable regression identified age above 65, smoking, diabetes, and physical inactivity as the strongest independent predictors of MACE outcomes.

Keywords: hypertension, cardiovascular disease, MACE, blood pressure, RCT, ESC guidelines, telemedicine, risk stratification, France, preventive cardiology

References

1. [1] Beaumont, F., Wiśniewska, K., & Eriksson, L. (2023). Telemedicine-supported hypertension management in European primary prevention cohorts: A feasibility study. European Journal of Preventive Cardiology, 30(4), 318–328.
2. [2] Bundy, J. D., Li, C., Stuchlik, P., et al. (2017). Systolic blood pressure reduction and risk of cardiovascular disease and mortality. JAMA Cardiology, 2(7), 775–781.
3. [3] ESC/ESH. (2018). 2018 ESC/ESH Guidelines for the management of arterial hypertension. European Heart Journal, 39(33), 3021–3104.
4. [4] EUROASPIRE V. (2019). European Society of Cardiology, European Atherosclerosis Society study. European Journal of Preventive Cardiology, 26(8), 824–835.
5. [5] GBD 2019 Risk Factors Collaborators. (2020). Global burden of 87 risk factors. Lancet, 396(10258), 1223–1249.
6. [6] Kjeldsen, S. E., Narkiewicz, K., Burnier, M., & Oparil, S. (2020). Hypertension management 2020. Blood Pressure, 29(1), 1–5.
7. [7] Lewington, S., Clarke, R., Qizilbash, N., et al. (2002). Age-specific relevance of usual blood pressure to vascular mortality. Lancet, 360(9349), 1903–1913.
8. [8] Muntner, P., Carey, R. M., Gidding, S., et al. (2018). Potential US population impact of the 2017 ACC/AHA blood pressure guideline. JAMA, 319(9), 900–910.
9. [9] Papadopoulos, D., Eriksson, L., & Beaumont, F. (2022). Blood pressure trajectory modelling in telemedicine-supported hypertension management. Journal of Hypertension, 40(8), 1584–1593.
10. [10] Poulter, N. R., Prabhakaran, D., & Caulfield, M. (2015). Hypertension. Lancet, 386(9995), 801–812.
11. [11] Roth, G. A., Johnson, C., Abajobir, A., et al. (2017). Global, regional, and national burden of cardiovascular diseases. Journal of the American College of Cardiology, 70(1), 1–25.
12. [12] Sega, R., Facchetti, R., Bombelli, M., et al. (2005). Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population. Circulation, 111(14), 1777–1783.
13. [13] Verdecchia, P., Angeli, F., Mazzotta, G., et al. (2011). Day-night dip and early morning surge in blood pressure. American Journal of Hypertension, 24(6), 605–611.
14. [14] Whelton, P. K., Carey, R. M., Aronow, W. S., et al. (2018). 2017 ACC/AHA hypertension guideline. Journal of the American College of Cardiology, 71(19), e127–e248.
15. [15] Wiśniewska, K., Brandt, M., & Papadopoulos, D. (2022). Five-year blood pressure control rates in Eastern European hypertension cohorts. Journal of Clinical Hypertension, 24(6), 712–721.

Explore Our Related Journals

Looking for the right journal for your next manuscript? Explore our international peer-reviewed journals covering engineering, management, computer science, artificial intelligence and multidisciplinary research.